9IEO
Human Deoxyhypusine Synthase Fragment Screening Campaign - ligand VT00438
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | MAX IV BEAMLINE BioMAX |
| Synchrotron site | MAX IV |
| Beamline | BioMAX |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2021-11-13 |
| Detector | DECTRIS EIGER2 X 16M |
| Wavelength(s) | 0.9763 |
| Spacegroup name | P 32 2 1 |
| Unit cell lengths | 105.020, 105.020, 160.750 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 46.160 - 1.680 |
| R-factor | 0.19518 |
| Rwork | 0.194 |
| R-free | 0.21072 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.017 |
| RMSD bond angle | 1.853 |
| Data reduction software | XDS |
| Data scaling software | XDS |
| Phasing software | DIMPLE |
| Refinement software | REFMAC (5.8.0419) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 46.160 | 46.160 | 1.780 |
| High resolution limit [Å] | 1.680 | 5.020 | 1.680 |
| Rmerge | 0.123 | 0.043 | 2.190 |
| Rmeas | 0.129 | 0.045 | 2.294 |
| Number of reflections | 116629 | 4674 | 18653 |
| <I/σ(I)> | 12.37 | 47.42 | 1.09 |
| Completeness [%] | 99.9 | 99.8 | 99.7 |
| Redundancy | 11.3 | ||
| CC(1/2) | 0.999 | 0.999 | 0.701 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 293 | 0.025-0.125 mM carboxylic acid mix, 30-60% precipitant mix (MPD, PEG 1000, PEG 3350), 100 mM Tris-Bicine pH = 8.5 |






